p53 protein overexpression and chemosensitivity in breast cancer.
Makris
A
A
Powles
T J
TJ
Dowsett
M
M
Allred
C
C
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008942:Mitoxantrone / Q000627:therapeutic use; D009154:Mutation; D013629:Tamoxifen / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
D016159:Tumor Suppressor Protein p53; D013629:Tamoxifen; D008942:Mitoxantrone; D008727:Methotrexate